A patient with a history of asthma and seasonal allergies presents with worsening symptoms. Pulmonary function tests show an FEV1 at 60% of the predicted value and a reduced FEV1/FVC ratio. Laboratory results indicate an elevated eosinophil count and serum IgE level. Which of the following nursing interventions should be prioritized to address the patient's current condition?

B) Educate the patient on the proper use of a peak flow meter to monitor asthma control.

A) Encourage the patient to increase physical activity to improve lung capacity.

B) Educate the patient on the proper use of a peak flow meter to monitor asthma control.

C) Advise the patient to avoid all potential allergens to prevent further exacerbations.

D) Suggest the use of a short-acting beta-agonist before engaging in physical activity.

A patient with a history of asthma presents with worsening symptoms, and diagnostic results indicate moderate obstruction with elevated eosinophils and IgE levels. Which intervention should the nurse prioritize to address the underlying cause of the patient's symptoms?

B) Educate the patient on the importance of adhering to a long-acting beta-agonist (LABA) and inhaled corticosteroid regimen.

A) Administer a short-acting beta-agonist (SABA) as needed for quick relief of asthma symptoms.

B) Educate the patient on the importance of adhering to a long-acting beta-agonist (LABA) and inhaled corticosteroid regimen.

C) Suggest the use of a leukotriene receptor antagonist to control allergic inflammation.

D) Recommend a referral to an allergist for potential allergen immunotherapy.

A patient with a history of asthma presents with increased nocturnal symptoms and a decreased FEV1. Which of the following nursing interventions is most appropriate to address the patient's current condition?

B) Encourage the patient to maintain a sleep diary to identify triggers.

A) Educate the patient on using a rescue inhaler before bedtime.

B) Encourage the patient to maintain a sleep diary to identify triggers.

C) Advise the patient to increase fluid intake to thin secretions.

D) Recommend the patient use a humidifier in the bedroom.

A patient with a history of asthma presents with increased shortness of breath at night and a persistent cough not relieved by current medications. Pulmonary function tests show a decreased FEV1 and a low FEV1/FVC ratio. Which nursing intervention is most appropriate to address the patient's current symptoms and improve respiratory status?

A) Administer a nebulized bronchodilator and assess peak flow after treatment

B) Encourage the patient to perform pursed-lip breathing to decrease respiratory rate

C) Suggest that the patient increase fluid intake to help thin mucus secretions

D) Educate the patient on using a rescue inhaler only during daytime hours to prevent overuse

A patient with eosinophilic asthma is experiencing nocturnal exacerbations despite being on high-dose inhaled corticosteroids and a leukotriene receptor antagonist. Which nursing action is most appropriate to address the patient's ongoing symptoms?

D) Recommend the patient undergo allergen testing for targeted environmental control.

A) Educate the patient on the use of a spacer with inhaled medications to improve delivery.

B) Suggest the patient use a humidifier in the bedroom to reduce nocturnal symptoms.

C) Encourage the patient to take an additional dose of corticosteroid in the evening.

D) Recommend the patient undergo allergen testing for targeted environmental control.

A patient with eosinophilic asthma is experiencing nocturnal exacerbations despite being on a high-dose inhaled corticosteroid and leukotriene receptor antagonist. Which nursing intervention is most appropriate to help manage the patient's symptoms?

C) Educate the patient on peak flow monitoring to identify early signs of exacerbation

A) Encourage the patient to increase fluid intake to thin secretions

B) Recommend the use of a humidifier at night to reduce airway irritation

C) Educate the patient on peak flow monitoring to identify early signs of exacerbation

D) Advise the patient to increase physical activity to improve lung function

A patient with eosinophilic asthma presents with acute respiratory distress and an arterial blood gas analysis indicating respiratory alkalosis. Which nursing intervention should be prioritized to address the patient's immediate respiratory needs?

B) Provide supplemental oxygen to maintain adequate oxygen saturation levels.

A) Administer a scheduled dose of long-acting bronchodilator.

B) Provide supplemental oxygen to maintain adequate oxygen saturation levels.

C) Encourage the patient to perform deep breathing exercises to reduce anxiety.

D) Educate the patient about the importance of avoiding known asthma triggers.

A patient in the emergency department with a history of asthma exacerbation is receiving high-flow nasal cannula therapy after systemic corticosteroids and supplemental oxygen showed minimal improvement in respiratory status. Which nursing intervention should be prioritized to prevent further deterioration of her condition?

B) Monitor for signs of respiratory fatigue and prepare for possible intubation.

A) Encourage deep breathing exercises to improve lung expansion.

B) Monitor for signs of respiratory fatigue and prepare for possible intubation.

C) Increase the flow rate of the nasal cannula to enhance oxygen delivery.

D) Administer a bronchodilator to relieve airway obstruction.

A patient in the emergency department is being treated for an asthma exacerbation with systemic corticosteroids and oxygen therapy. Despite these interventions, she shows signs of respiratory fatigue and an elevated eosinophil count. The healthcare team decides to initiate high-flow nasal cannula therapy and consider biologic therapy targeting IL-5. What is the primary nursing consideration in monitoring the effectiveness of these interventions?

C) Assessing the patient's respiratory rate and oxygen saturation levels

A) Monitoring the patient's heart rate for signs of tachycardia

B) Evaluating the patient's skin for signs of an allergic reaction

C) Assessing the patient's respiratory rate and oxygen saturation levels

D) Checking the patient's blood pressure for hypotension

asthma - Nursing Case Study

Pathophysiology

• Primary mechanism: Bronchial hyperresponsiveness leads to the narrowing of airways due to inflammation and smooth muscle contraction, triggered by allergens, irritants, or infections. This results in wheezing, coughing, and difficulty breathing.

• Secondary mechanism: Chronic inflammation causes airway remodeling, characterized by thickening of the airway walls and increased mucus production. This exacerbates airflow obstruction and contributes to persistent symptoms.

• Key complication: Repeated asthma exacerbations can lead to irreversible changes in airway structure and function, increasing the risk of respiratory failure and decreased quality of life.

Patient Profile

Demographics:

45-year-old female, school teacher

History:

• Key past medical history: Diagnosed with asthma 10 years ago, history of seasonal allergies, and occasional sinusitis

• Current medications: Inhaled corticosteroid (Fluticasone) daily, Albuterol inhaler as needed, and Montelukast

• Allergies: Allergic to penicillin and dust mites

Current Presentation:

• Chief complaint: Increased shortness of breath and wheezing over the past two weeks

• Key symptoms: Persistent cough, tightness in the chest, and frequent nighttime awakenings due to difficulty breathing

• Vital signs: Temperature 98.8°F, heart rate 110 bpm, respiratory rate 24 breaths per minute, blood pressure 135/85 mmHg, oxygen saturation 92% on room air

Section 1

New Diagnostic Results:

Following the initial assessment, further diagnostic tests were conducted to better understand the underlying causes of the patient's worsening asthma symptoms and to evaluate the extent of airway involvement. Pulmonary function tests (PFTs) revealed a decreased forced expiratory volume in one second (FEV1) at 60% of the predicted value, indicating moderate obstruction. The FEV1/FVC ratio was also reduced, confirming airflow limitation consistent with obstructive lung disease. Additionally, a chest X-ray was performed to rule out any underlying infections or complications such as pneumonia or pneumothorax, and it showed mild hyperinflation of the lungs but no acute infiltrates.

Laboratory results showed an elevated eosinophil count, suggesting ongoing allergic inflammation, which aligns with her history of seasonal allergies and asthma. The serum IgE level was also elevated, reinforcing the likelihood of an allergic component exacerbating her symptoms. Arterial blood gas analysis indicated mild respiratory alkalosis with a pH of 7.47 and a partial pressure of carbon dioxide (PaCO2) of 33 mmHg, reflecting hyperventilation due to increased respiratory effort. These findings suggest that despite the use of her current medication regimen, there is inadequate control of her asthma, necessitating a reassessment of her treatment plan.

Based on these results, the healthcare team considered adjusting her medication regimen to include a long-acting beta-agonist (LABA) in combination with her inhaled corticosteroid to provide better control over her symptoms. Furthermore, a referral to an allergist for possible immunotherapy was proposed to address her allergic triggers more effectively. This plan aims to prevent further exacerbations, mitigate the risk of chronic airway remodeling, and improve her overall quality of life. As the patient's condition is monitored, the team will continue to evaluate the effectiveness of these interventions and make adjustments as necessary to optimize her asthma management.

Section 2

Several weeks into the adjusted treatment plan, the patient returned to the clinic with new complaints of increased shortness of breath, especially during nighttime, and a persistent cough that was not alleviated by her current medications. During the assessment, her vital signs revealed a heart rate of 102 beats per minute, respiratory rate of 24 breaths per minute, and an oxygen saturation of 92% on room air, suggesting possible hypoxemia and increased work of breathing. Auscultation of her lungs indicated diffuse wheezing, more pronounced on expiration, and reduced breath sounds at the bases, raising concerns about potential complications.

In response to these new symptoms, a repeat pulmonary function test was conducted, which showed a further decrease in FEV1 to 55% of the predicted value, highlighting a worsening in airflow obstruction. The FEV1/FVC ratio remained low, consistent with ongoing airway limitation. In light of her nocturnal symptoms and elevated eosinophil count, there was a suspicion of developing nocturnal asthma exacerbations and possibly an underlying condition such as eosinophilic asthma. These findings pointed to the need for a more aggressive management approach, potentially including the addition of a leukotriene receptor antagonist or biologic therapy targeting eosinophils.

Given the patient's deteriorating status and the limited response to adjusted therapies, the healthcare team decided to initiate a high-dose inhaled corticosteroid regimen and reassess the need for long-acting muscarinic antagonists (LAMAs) to enhance bronchodilation. Additionally, close monitoring through peak flow measurements and a symptom diary was recommended to better track her response to treatment and identify any triggers. The situation necessitated another referral to a specialist for further evaluation and potential adjustment in her long-term management strategy, aiming to prevent further complications such as chronic obstruction or irreversible airway remodeling.

Section 3

After initiating the high-dose inhaled corticosteroid regimen and incorporating a leukotriene receptor antagonist, the patient returned for a follow-up visit two weeks later. Notably, she reported some improvement in her daytime symptoms, but continued to struggle with nocturnal awakenings due to shortness of breath and cough. Her peak flow measurements, documented in the symptom diary, showed significant variability with a morning dip, suggesting ongoing nocturnal asthma exacerbations.

During this visit, her vital signs indicated a heart rate of 96 beats per minute, a respiratory rate of 22 breaths per minute, and oxygen saturation of 94% on room air. Although there was slight improvement, her breathing still appeared labored. Lung auscultation revealed persistent diffuse wheezing, particularly on expiration, and continued diminished breath sounds at the bases. A follow-up eosinophil count remained elevated, further supporting the diagnosis of eosinophilic asthma. These findings prompted a reevaluation of her medication regimen, with consideration for initiating biologic therapy specifically targeting eosinophils.

Recognizing the potential for chronic complications if her condition did not stabilize, the healthcare team emphasized the importance of environmental control and allergen avoidance as adjunct strategies. They scheduled a comprehensive review with a pulmonologist to explore the possibility of biologic treatments such as anti-IL-5 therapy, which could offer more targeted control of her eosinophilic-driven symptoms. This approach aimed to improve her quality of life and prevent further airway damage, paving the way for a more personalized treatment plan.

Section 4

As the healthcare team awaited the pulmonologist's evaluation, the patient experienced a change in her status that warranted immediate attention. Three days after the follow-up visit, she presented to the emergency department with worsening respiratory symptoms. Her vital signs showed a heart rate of 110 beats per minute, a respiratory rate of 28 breaths per minute, and an oxygen saturation of 90% on room air. She appeared anxious and was using accessory muscles to breathe, indicating increased respiratory distress. Upon assessment, lung auscultation revealed louder wheezing throughout the lung fields, with diminished breath sounds more pronounced at the bases compared to previous evaluations.

Laboratory tests revealed significant results: her eosinophil count had increased further, and an arterial blood gas analysis indicated respiratory alkalosis with a pH of 7.48 and a PaCO2 of 32 mmHg, suggesting hyperventilation due to her increased work of breathing. These findings pointed to an acute exacerbation of her eosinophilic asthma, likely triggered by a recent exposure or an ongoing inadequately controlled inflammatory process. Given her deteriorating condition, the clinical team decided to initiate systemic corticosteroids to rapidly reduce inflammation and considered immediate initiation of biologic therapy targeting IL-5 to address the eosinophilic component directly.

This acute episode highlighted the complexities of managing eosinophilic asthma and underscored the importance of timely interventions to prevent severe complications. The patient's response to systemic corticosteroids would be closely monitored, and the initiation of biologic therapy would be expedited as part of her evolving treatment plan. The healthcare team prepared to educate her on recognizing early signs of exacerbation and the importance of adherence to her updated management regimen to avoid future complications.

Section 5

As the emergency department team continued to care for the patient, her initial response to systemic corticosteroids was assessed over the next several hours. Despite the intervention, her respiratory status showed minimal improvement, with continued use of accessory muscles and persistent tachypnea. Her respiratory rate remained elevated at 26 breaths per minute, and her oxygen saturation fluctuated between 88-90% on room air, prompting the need for supplemental oxygen via nasal cannula to maintain saturations above 92%. The patient's level of anxiety had slightly decreased, although she still appeared visibly uncomfortable and fatigued.

A repeat arterial blood gas analysis was performed to evaluate the effectiveness of the treatment and revealed a pH of 7.45 and a PaCO2 of 34 mmHg, indicating a partial compensation of the respiratory alkalosis. Despite the correction, her clinical picture suggested a progression towards respiratory fatigue, raising concerns about potential impending respiratory failure. The decision was made to initiate high-flow nasal cannula therapy to better support her work of breathing and improve oxygenation.

Concomitantly, a new set of laboratory tests revealed an elevated C-reactive protein level, indicating an ongoing inflammatory response. The eosinophil count remained high, reinforcing the need to expedite the initiation of biologic therapy targeting IL-5. The pulmonologist, now involved in her care, emphasized the urgency of addressing both the inflammatory and obstructive components of her condition to prevent further complications. The healthcare team also reviewed her recent environmental exposures and medication adherence to identify potential triggers and adjust her long-term asthma management plan accordingly. This approach aimed to stabilize her condition and reduce the risk of future exacerbations, guiding the next steps in her care trajectory.